Arbutus Biopharma Files 8-K on Shareholder Vote Matters
Ticker: ABUS · Form: 8-K · Filed: May 23, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, shareholder-vote, corporate-event
TL;DR
Arbutus Biopharma filed an 8-K for a shareholder vote on May 21st.
AI Summary
Arbutus Biopharma Corp. filed an 8-K on May 23, 2025, reporting on matters submitted to a vote of security holders as of May 21, 2025. The filing indicates a change in the company's reporting status or a significant corporate event requiring disclosure.
Why It Matters
This filing signals that Arbutus Biopharma has held or is preparing to hold a shareholder vote on important corporate matters, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of a shareholder vote, not indicative of immediate financial distress or significant operational changes.
Key Numbers
- 001-34949 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-0597776 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Arbutus Biopharma Corp. (company) — Registrant
- TEKMIRA PHARMACEUTICALS Corp (company) — Former company name
- May 21, 2025 (date) — Date of earliest event reported
- May 23, 2025 (date) — Filing date
FAQ
What specific matters were submitted to a vote of Arbutus Biopharma's security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were reported on as of May 21, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 21, 2025.
What is the principal executive office address for Arbutus Biopharma Corp?
The principal executive offices are located at 701 Veterans Circle, Warminster, Pennsylvania, 18974.
What was Arbutus Biopharma Corp. formerly known as?
Arbutus Biopharma Corp. was formerly known as TEKMIRA PHARMACEUTICALS Corp.
What is the filing date of this 8-K report?
This 8-K report was filed on May 23, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Arbutus Biopharma Corp (ABUS).